Chemotherapy combined with radiotherapy is the traditional treatment for oropharyngeal cancer. All cancer treatments can have side effects, but radiotherapy for this form of the disease often ...
Ligufalimab is under clinical development by Akeso and currently in Phase II for Oropharyngeal Cancer. According to GlobalData, Phase II drugs for Oropharyngeal Cancer have a 50% phase transition ...
Researchers observed a dose-response relationship between daily tea consumption and the risk of head and neck cancer, hypopharyngeal cancer, and laryngeal cancer.